RxDoctor Payments Data

Ralph Junius, MD

Orthopaedic Surgery · Metairie, LANPI 1659464618

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $102,375 of the $157,570 with a category attached, or 65.0%. 14 manufacturers reported payments, led by Zimmer Biomet at 57.7% of the total. Reporting peaked in 2021 at $38,770 and has fallen 83.1% since, to $6,553 in 2025. Among orthopaedic surgery clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$157,570in general payments, 2019–2025

Across 361 payments — averaging $436.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$91K
  • Stryker$36K
  • Medtronic$24K
  • Smith+Nephew$3K
  • Lima USA, Inc.$1K
  • Johnson & Johnson$1K
  • plus $612 from 8 others

What the payments were for

  • Consulting fees$102,37565%
  • Speaking & faculty fees$17,61011%
  • Travel & lodging$25,48616%
  • Food & beverage$12,0818%
  • Education$180%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$157,570 in reported general payments places this provider in the 95th percentile of 286 orthopaedic surgery providers in Louisiana.

See all orthopaedic surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$363,201
Medicare patients
533
Services billed
7,471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib41$533
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen35$400
Methylprednisolone27$199
Tramadol Hcl34$190
Meloxicam30$132
Ibuprofen12$122

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →